JP2011168522A - TESTOSTERONE-5alpha-REDUCTASE INHIBITOR - Google Patents

TESTOSTERONE-5alpha-REDUCTASE INHIBITOR Download PDF

Info

Publication number
JP2011168522A
JP2011168522A JP2010033083A JP2010033083A JP2011168522A JP 2011168522 A JP2011168522 A JP 2011168522A JP 2010033083 A JP2010033083 A JP 2010033083A JP 2010033083 A JP2010033083 A JP 2010033083A JP 2011168522 A JP2011168522 A JP 2011168522A
Authority
JP
Japan
Prior art keywords
extract
hair
cherry
pimple
reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010033083A
Other languages
Japanese (ja)
Other versions
JP5971833B2 (en
Inventor
Kosuke Fukada
紘介 深田
Tsutomu Sakaida
勉 坂井田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Menard Cosmetic Co Ltd
Original Assignee
Nippon Menard Cosmetic Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Menard Cosmetic Co Ltd filed Critical Nippon Menard Cosmetic Co Ltd
Priority to JP2010033083A priority Critical patent/JP5971833B2/en
Publication of JP2011168522A publication Critical patent/JP2011168522A/en
Application granted granted Critical
Publication of JP5971833B2 publication Critical patent/JP5971833B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a 5α-reductase inhibitor, a hair grower, a pimple therapeutic agent and a prostate disease therapeutic agent which contain Arcterica nana. <P>SOLUTION: The extract of Arcterica nana has an excellent 5α-reductase inhibitory action. A hair grower and a pimple treatment ointment containing the extract exhibit excellent hair restoration effect, pimple preventing and treating effect, respectively and have excellent safety and stability. Consequently, the 5α-reductase inhibitor is effective for preventing and treating male pattern alopecia, pimple, prostate disease, etc. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、新規なテストステロン‐5α‐レダクターゼ(以下5α‐レダクターゼと略す)阻害剤、育毛剤、ニキビ治療剤及び前立腺疾患治療剤に関する。 The present invention relates to a novel testosterone-5α-reductase (hereinafter abbreviated as 5α-reductase) inhibitor, hair restorer, acne treatment agent and prostate disease treatment agent.

従来より、男性型脱毛症の成因としては、(1)ホルモンのアンバランス説、(2)遺伝説、(3)血液循環不全説、(4)栄養説等が提唱されているが、毛の発生には男性ホルモンのテストステロンが重要な役割を演じていることが古くから示唆されている。すなわち、睾丸で生合成されたテストステロンは、頭部において毛包、皮脂腺等に存在する5α‐レダクターゼによりジヒドロテストステロンに転換される。このジヒドロテストステロンは、アデニルサイクラーゼの活性を著しく低下させて細胞内サイクリックAMPレベルの低下をもたらす。その結果、毛及び毛の周辺のエネルギー産生の低下とタンパク合成の抑制を誘起することにより男性型脱毛症が進行するものと考えられている。 Conventionally, the cause of male pattern alopecia has been proposed as (1) hormone imbalance theory, (2) genetic theory, (3) blood circulation failure theory, (4) nutrition theory, etc. It has long been suggested that the male hormone testosterone plays an important role in the outbreak. That is, testosterone biosynthesized by testicles is converted to dihydrotestosterone by 5α-reductase present in hair follicles, sebaceous glands and the like in the head. This dihydrotestosterone significantly reduces the activity of adenyl cyclase resulting in a decrease in intracellular cyclic AMP levels. As a result, it is considered that male pattern baldness progresses by inducing a decrease in energy production around hair and hair and suppression of protein synthesis.

また、テストステロンから5α‐レダクターゼによって生成するジヒドロテストステロンは、ニキビの発生や増悪に関与するものと考えられている(非特許文献1参照)。さらに、ジヒドロテストステロンの生成が高まると、前立腺肥大症、前立腺癌等の前立腺疾患が発症することも知られており、5α‐レダクターゼ阻害作用を有する薬剤によりジヒドロテストステロンの生成を抑制または阻害することができれば、前立腺疾患を予防し、治療することができると考えられる。 Further, dihydrotestosterone produced from testosterone by 5α-reductase is considered to be involved in acne generation and exacerbation (see Non-Patent Document 1). Furthermore, it is known that when the production of dihydrotestosterone increases, prostate diseases such as prostatic hypertrophy and prostate cancer develop, and it is possible to suppress or inhibit the production of dihydrotestosterone by a drug having a 5α-reductase inhibitory action. If possible, it is believed that prostate disease can be prevented and treated.

J.Steroid Biochemistry,11,609(1979)J. et al. Steroid Biochemistry, 11, 609 (1979)

従って、これらの疾患に対する有効な薬剤、特にジヒドロテストステロン生成抑制に基づく有効な薬剤の開発が望まれていた。 Accordingly, it has been desired to develop effective drugs for these diseases, particularly effective drugs based on the suppression of dihydrotestosterone production.

本発明者らは、上記課題の解決に向け鋭意検討を行った結果、コメバツガザクラの抽出物が優れた5α‐レダクターゼ阻害作用を有することを見出した。さらに、その抽出物を含有する薬剤が安全で安定であり、育毛効果とニキビ改善効果に優れていることを見出し、本発明を完成するに至った。 As a result of intensive studies aimed at solving the above problems, the present inventors have found that an extract of rice bran cherry has an excellent 5α-reductase inhibitory action. Furthermore, the present inventors have found that a drug containing the extract is safe and stable and is excellent in a hair-growth effect and an acne improvement effect, and has completed the present invention.

本発明で用いられるコメバツガザクラの抽出物とは、ツツジ科コメバツガザクラ属の植物、コメバツガザクラ(学名:Arcterica nana)(別名:ハマザクラ)の花、花穂、茎、葉、枝、枝葉、根、種子等の植物体の一部又は全草から抽出したものである。その抽出方法は特に限定されず、例えば、加熱抽出したものであっても良いし、常温抽出したものであっても良い。植物材料は、生のまま用いても乾燥して用いてもよい。細断することにより抽出効率を上げることができる。 The extract of the rice crabs used in the present invention is a plant belonging to the genus Comebaceae genus, the plant of the genus Combata zakura (scientific name: Arcterica nana) (also known as: Hamazakura), flowers, ears, stems, leaves, branches, branches, leaves, roots, seeds, etc. It is extracted from part of the body or whole grass. The extraction method is not particularly limited, and for example, it may be a heat extraction or a room temperature extraction. The plant material may be used raw or dried. Shredding can increase extraction efficiency.

抽出する溶媒としては、例えば、水、低級アルコール類(メタノール、エタノール、1‐プロパノール、2‐プロパノール、1‐ブタノール、2‐ブタノール等)、液状多価アルコール(1,3‐ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン、流動パラフィン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。好ましくは、水、低級アルコール及び液状多価アルコール等の極性溶媒が良く、特に好ましくは、水、エタノール、1,3‐ブチレングリコール及びプロピレングリコールが良い。これらの溶媒は一種でも二種以上を混合して用いても良い。 Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol). , Glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether) Etc.). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, 1,3-butylene glycol and propylene glycol. These solvents may be used alone or in combination of two or more.

上記抽出物は、抽出した溶液のまま用いても良く、必要に応じて、濃縮、希釈及び濾過処理、活性炭等による脱色、脱臭処理等をして用いても良い。更には、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いても良い。 The extract may be used as it is, or may be used after concentration, dilution and filtration treatment, decolorization with activated carbon, deodorization treatment, or the like, if necessary. Further, the extracted solution may be subjected to a treatment such as concentration to dryness, spray drying, freeze drying, etc., and used as a dried product.

本発明の5α‐レダクターゼ阻害剤、育毛剤あるいはニキビ治療剤全組成中の抽出物の配合量は抽出固形分として、0.001〜10重量%(以下単に%で示す)であればよく、より好ましくは0.01〜5%である。0.001%未満では本発明の目的とする効果が十分ではなく、一方上限を越えても、その増加分に見合った効果の向上は望みにくいものである。 The blending amount of the extract in the total composition of the 5α-reductase inhibitor, hair restorer or acne treatment agent of the present invention may be 0.001 to 10% by weight (hereinafter simply referred to as “%”) as the extracted solid content. Preferably it is 0.01 to 5%. If it is less than 0.001%, the intended effect of the present invention is not sufficient. On the other hand, even if the upper limit is exceeded, an improvement in the effect commensurate with the increase is hardly expected.

また、本発明の育毛剤及びニキビ治療剤は抽出物の他に必要に応じて、添加剤及び育毛剤あるいはニキビ治療剤として慣用されている他の薬剤を本発明の効果を損なわない範囲で適宜配合することができる。添加剤としては、例えば、ヒノキチオール、塩化ベンザルコニウム、ヘキサクロロフェン、ウンデシレン酸等の抗菌剤、メントール等の清涼剤、高級脂肪酸、高級アルコール類、界面活性剤、香料、酸化防止剤、エタノール、精製水、保湿剤等が挙げられる。また、育毛剤として慣用されている他の薬剤としては、例えば、センブリエキス、アセチルコリン誘導体等の血管拡張剤、スウェルチノーゲン、ビタミンEニコチン酸エステル、トウガラシチンキ、朝鮮ニンジン等を挙げることができ、これらを1種または2種以上使用することができる。さらに、ニキビ治療剤として慣用されている他の薬剤としては、例えば、吉草酸酢酸プレドニゾロン、酢酸ヒドロコルチゾン等のステロイド剤、アスコルビン酸、塩酸ピリドキシン等のビタミン剤、アラントイン等の創傷治癒剤等を挙げることができ、これらを1種または2種以上使用することができる。 In addition to the extract, the hair restorer and acne treatment agent of the present invention are appropriately selected from additives and other agents conventionally used as hair restorers or acne treatment agents as long as the effects of the present invention are not impaired. Can be blended. Examples of additives include antibacterial agents such as hinokitiol, benzalkonium chloride, hexachlorophene and undecylenic acid, refreshing agents such as menthol, higher fatty acids, higher alcohols, surfactants, perfumes, antioxidants, ethanol, purification Water, a humectant, etc. are mentioned. Examples of other drugs that are commonly used as hair restorers include vasodilators such as assembly extract and acetylcholine derivatives, swelltinogen, vitamin E nicotinic acid ester, red pepper tincture, and ginseng. One or more of these can be used. In addition, other drugs commonly used as acne treatments include, for example, steroids such as prednisolone valerate acetate and hydrocortisone acetate, vitamins such as ascorbic acid and pyridoxine hydrochloride, and wound healing agents such as allantoin. These can be used alone or in combination of two or more.

本発明の育毛剤は、外用剤として用いられるものであればその剤型については制限されるものではなく、例えば、ヘアトニック、ヘアローション、ヘアクリーム、ヘアコンディショナー、ヘアジェル、ヘアミスト、ヘアフォーム、シャンプー、リンス等が挙げられる。また、ニキビ治療剤についても、外用剤として用いられるものであればその剤型については制限されるものではなく、例えば、軟膏、液剤、貼付剤、噴霧剤等が挙げられる。また、本発明の5α‐レダクターゼ阻害剤は、経口にも適用でき、製剤としては、錠剤、カプセル剤、散剤、細粒剤、顆粒剤、内服液剤等の剤型を挙げることができる。 The hair growth agent of the present invention is not limited as long as it is used as an external preparation. For example, hair tonic, hair lotion, hair cream, hair conditioner, hair gel, hair mist, hair foam, shampoo , Rinse and the like. The acne treatment agent is not limited as long as it is used as an external preparation, and examples thereof include ointments, liquids, patches, sprays and the like. In addition, the 5α-reductase inhibitor of the present invention can be applied orally, and examples of the preparation include dosage forms such as tablets, capsules, powders, fine granules, granules, oral liquids and the like.

本発明のコメバツガザクラの抽出物は、優れた5α‐レダクターゼ阻害効果、育毛効果及びニキビ治療効果を示した。また、前立腺疾患の治療にも有効である。 The extract of the rice bran cherry of the present invention showed an excellent 5α-reductase inhibitory effect, hair growth effect and acne treatment effect. It is also effective in treating prostate diseases.

次に本発明を詳細に説明するため、実施例として本発明に用いる抽出物の製造例、本発明の処方例及び実験例を挙げるが、本発明はこれに限定されるものではない。実施例に示す配合量の部とは重量部を、%とは重量%を示す。 Next, in order to describe the present invention in detail, examples of producing the extract used in the present invention, formulation examples and experimental examples of the present invention will be given as examples, but the present invention is not limited thereto. In the examples, the part of the amount is part by weight, and% is% by weight.

製造例1 コメバツガザクラの熱水抽出物
コメバツガザクラ(Arcterica nana)の全草の乾燥物20gに精製水400mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してコメバツガザクラの熱水抽出物を1.0g得た。
Production Example 1 Hot Water Extract of Rice Butter Crab 400 mL of purified water is added to 20 g of dried dried whole plant of Arcterica nana, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate is concentrated and lyophilized As a result, 1.0 g of a hot water extract of rice bran cherry was obtained.

製造例2 コメバツガザクラの50%エタノール抽出物
コメバツガザクラ(Arcterica nana)の全草の乾燥物20gに50%エタノール水溶液400mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、コメバツガザクラの50%エタノール抽出物を1.5g得た。
Production Example 2 50% Ethanol Extract of Rice Butter Crab (Arterica nana) Whole plant dry product 20 g was added with 400 mL of 50% ethanol aqueous solution, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness. 1.5 g of a 50% ethanol extract of rice bran cherry was obtained.

製造例3 コメバツガザクラのエタノール抽出物
コメバツガザクラ(Arcterica nana)の全草の乾燥物50gにエタノール1000mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、コメバツガザクラのエタノール抽出物を1.4g得た。
Production Example 3 Ethanol extract of Kumebatsuzakura 1000 mL of ethanol was added to 50 g of dried plant of Arcterica nana, extracted at room temperature for 7 days, filtered, the filtrate was concentrated to dryness, and ethanol extraction of Kumebatsuzakura 1.4 g of product was obtained.

製造例4 コメバツガザクラの50%1,3‐ブチレングリコール抽出物
コメバツガザクラ(Arcterica nana)の全草の乾燥物20gに50%1,3‐ブチレングリコール水溶液400mLを加え、常温で7日間抽出した後、濾過し、コメバツガザクラの50%1,3‐ブチレングリコール抽出物を380g得た。
Production Example 4 Extract of 50% 1,3-butylene glycol from Kumebatsuzakura 400 mL of a 50% 1,3-butyleneglycol aqueous solution was added to 20 g of a dry product of whole plant of Kumebatsuzakura (Arterica nana), extracted at room temperature for 7 days, and filtered. As a result, 380 g of 50% 1,3-butylene glycol extract of rice bran cherry was obtained.

処方例1 ヘアローション
処方 配合量(部)
1.コメバツガザクラの熱水抽出物(製造例1) 0.2
2.ステアリン酸 5.0
3.セチルアルコール 5.0
4.流動パラフィン 2.0
5.グリセリンモノステアレート 1.3
6.ソルビタンモノステアレート 1.5
7.ポリオキシエチレン(10)ソルビタンモノオレート 0.8
8.グリセリン 6.0
9.防腐剤 適量
10.精製水にて全量を100とする
[製造方法]成分2〜7を加熱溶解して混合し、70℃に保ち油相とした。成分1および8〜10を加熱溶解して混合し、75℃に保ち水相とした。油相に水相を加え、かき混ぜながら冷却して製品とした。
Formulation Example 1 Hair Lotion Formulation Formulation (Part)
1. Hot water extract of rice bran cherry (Production Example 1) 0.2
2. Stearic acid 5.0
3. Cetyl alcohol 5.0
4). Liquid paraffin 2.0
5. Glycerin monostearate 1.3
6). Sorbitan monostearate 1.5
7). Polyoxyethylene (10) sorbitan monooleate 0.8
8). Glycerin 6.0
9. Preservative appropriate amount10. [Production method] Components 2 to 7 were heated and dissolved and mixed with purified water to 100. The oil phase was maintained at 70 ° C. Ingredients 1 and 8 to 10 were dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. An aqueous phase was added to the oil phase, and the mixture was cooled while stirring to obtain a product.

処方例2 ヘアトニック
処方 配合量(部)
1.コメバツガザクラのエタノール抽出物(製造例3) 2.0
2.95%エタノール 60.0
3.グリセリン 2.0
4.精製水にて全量を100とする
[製造方法]成分1を2に溶解し、成分3及び4を加え、十分撹拌混合し、製品とした。
Formulation Example 2 Hair Tonic Formulation Amount (parts)
1. Ethanol extract of rice bran cherry (Production Example 3) 2.0
2.95% ethanol 60.0
3. Glycerin 2.0
4). [Manufacturing method] Component 1 was dissolved in 2 with purified water to 100, and components 3 and 4 were added and mixed with sufficient stirring to obtain a product.

比較例1 従来のヘアトニック
処方例2において、成分1を精製水に置き換えたものを従来の製品とした。
Comparative Example 1 A conventional product was prepared by replacing component 1 with purified water in conventional hair tonic formulation example 2.

処方例3 シャンプー
処方 配合量(部)
1.コメバツガザクラの50%エタノール抽出物(製造例2) 0.1
2.アルキル硫酸トリエタノールアミン 18.0
3.ラウリン酸ジエタノールアミド 3.0
4.メチルセルロース 0.5
5.香料 適量
6.精製水にて全量を100とする
[製造方法]成分6に成分4を均一に溶解した後、成分1及び2を加え、70〜75℃で加熱溶解した後、成分3を加え、冷却途中に成分5を加え30℃まで冷却し製品とした。
Formulation Example 3 Shampoo Formulation Blending (parts)
1. 50% ethanol extract of rice bran cherry (Production Example 2) 0.1
2. Alkyl sulfate triethanolamine 18.0
3. Lauric acid diethanolamide 3.0
4). Methylcellulose 0.5
5. Perfume appropriate amount 6. [Manufacturing method] in which component 4 is uniformly dissolved in component 6 with purified water 100, components 1 and 2 are added, heated and dissolved at 70 to 75 ° C, component 3 is added, and cooling is in progress. Ingredient 5 was added and cooled to 30 ° C. to obtain a product.

処方例4 リンス
処方 配合量(部)
1.コメバツガザクラの50%1,3‐ブチレングリコール抽出物
(製造例4) 0.1
2.ホホバ油 0.01
3.ベヘニルアルコール 3.0
4.1,3‐ブチレングリコール 5.0
5.塩化ジステアリルジメチルアンモニウム(75%) 8.0
6.クエン酸 0.05
7.香料 適量
8.精製水にて全量を100とする
[製造方法]成分1〜8を60℃で溶解し、撹拌して30℃まで冷却し製品とした。
Formulation Example 4 Rinse Formulation Amount (parts)
1. 50% 1,3-butylene glycol extract of rice bran cherry (Production Example 4) 0.1
2. Jojoba oil 0.01
3. Behenyl alcohol 3.0
4.1,3-Butylene glycol 5.0
5. Distearyldimethylammonium chloride (75%) 8.0
6). Citric acid 0.05
7). Perfume appropriate amount 8. [Manufacturing method] Components 1 to 8 were dissolved at 60 ° C., and the total amount was 100 with purified water.

処方例5 ニキビ治療用軟膏
処方 配合量(部)
1.コメバツガザクラのエタノール抽出物(製造例3) 1.0
2.コメバツガザクラの50%1,3‐ブチレングリコール抽出物
(製造例4) 1.0
3.ポリオキシエチレンセチルエーテル(30E.O.) 2.0
4.モノステアリン酸グリセリン 10.0
5.流動パラフィン 5.0
6.セタノール 6.0
7.パラオキシ安息香酸メチル 0.1
8.プロピレングリコール 10.0
9.精製水にて全量を100とする
[製造方法]成分1及び3〜6を加熱溶解して混合し、70℃に保ち油相とした。成分2及び7〜9を加熱溶解して混合し、75℃に保ち水相とした。油相に水相を加えて乳化して、かき混ぜながら30℃まで冷却して製品とした。
Formulation Example 5 Acne Treatment Ointment Formulation Blending (parts)
1. Ethanol extract of rice bran cherry (Production Example 3) 1.0
2. 50% 1,3-butylene glycol extract of rice bran cherry (Production Example 4) 1.0
3. Polyoxyethylene cetyl ether (30E.O.) 2.0
4). Glycerol monostearate 10.0
5. Liquid paraffin 5.0
6). Cetanol 6.0
7). Methyl paraoxybenzoate 0.1
8). Propylene glycol 10.0
9. [Manufacturing method] Components 1 and 3 to 6 were heated and dissolved and mixed with purified water to 100. The oil phase was maintained at 70 ° C. Ingredients 2 and 7-9 were dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. The aqueous phase was added to the oil phase to emulsify, and the mixture was cooled to 30 ° C. with stirring to obtain a product.

比較例2 従来の軟膏
処方例5において、成分1を流動パラフィンに、成分2を50%1,3‐ブチレングリコールに置き換えたものを従来の製品とした。
Comparative Example 2 A conventional product was prepared by replacing Component 1 with liquid paraffin and Component 2 with 50% 1,3-butylene glycol in Conventional Ointment Formulation Example 5.

次に、本発明の効果を詳細に説明するため、実験例を挙げる。 Next, experimental examples will be given to explain the effects of the present invention in detail.

実験例1 5α‐レダクターゼ活性阻害試験
ラット肝ミクロソーム由来5α‐レダクターゼを用い、下記の反応系における条件で測定した。
テストステロン(終濃度0.49mM)をDMSOで溶解した後、NADPH(終濃度0.97mM)を0.1Mトリス‐塩酸緩衝液(pH7.2)で溶解したものを添加し、ついで試料及び5α‐レダクターゼを順に加え、37℃で30分間反応させた。反応後、等量のジクロロメタンを加えて反応を停止した後、ジクロロメタン層を抽出した。ついでジクロロメタン層を減圧下で留去し、BSTFAを用いてシリル化を行った後、ガスクロマトグラフィー質量分析装置にて常法により反応量を測定した。また、阻害率は、試料の代わりに精製水を用いたものを対照とし、対照の反応率を100%(阻害率0%)と見なし、試料を加えた反応量を算出して阻害率を求めた。算式は次の通りである。
Experimental Example 1 5α-Reductase Activity Inhibition Test Using rat liver microsome-derived 5α-reductase, measurement was performed under the following reaction conditions.
After dissolving testosterone (final concentration 0.49 mM) in DMSO, NADPH (final concentration 0.97 mM) dissolved in 0.1 M Tris-HCl buffer (pH 7.2) was added, and then the sample and 5α- Reductase was added in order and reacted at 37 ° C. for 30 minutes. After the reaction, an equal amount of dichloromethane was added to stop the reaction, and then the dichloromethane layer was extracted. Then, the dichloromethane layer was distilled off under reduced pressure, and after silylation using BSTFA, the reaction amount was measured by a conventional method using a gas chromatography mass spectrometer. The inhibition rate is determined by using purified water instead of the sample as a control, assuming that the control reaction rate is 100% (inhibition rate 0%), and calculating the amount of reaction with the sample added to determine the inhibition rate. It was. The formula is as follows.

阻害率(%)=(1−(b’/a’)/(b/a))×100
a :テストステロンのピーク面積(対照)
b :ジヒドロテストステロンのピーク面積(対照)
a’:テストステロンのピーク面積(試料添加)
b’:ジヒドロテストステロンのピーク面積(試料添加)
これらの結果をまとめて表1に示した。その結果、コメバツガザクラの抽出物は、優れた5α‐レダクターゼ活性阻害作用を示した。
Inhibition rate (%) = (1− (b ′ / a ′) / (b / a)) × 100
a: Peak area of testosterone (control)
b: Peak area of dihydrotestosterone (control)
a ′: Testosterone peak area (sample addition)
b ′: Peak area of dihydrotestosterone (sample addition)
These results are summarized in Table 1. As a result, the extract of the rice bran cherry showed an excellent inhibitory activity on 5α-reductase activity.

Figure 2011168522
Figure 2011168522

実験例2 育毛効果に関する使用試験
処方例2のヘアトニック及び比較例1の従来のヘアトニックを用いて、各々男性型脱毛症10人(42〜53歳)を対象に6カ月間の使用試験を行った。使用後、発毛や薄毛、脱毛についてアンケート調査を行い、総合的に判定した。その結果、コメバツガザクラの抽出物を含有する育毛剤は優れた育毛効果を示した(表2)。なお、試験期間中、皮膚トラブルは一人もなく、安全性においても問題なかった。また、処方成分の劣化についても問題なかった。
Experimental example 2 Use test on hair growth effect Using the hair tonic of prescription example 2 and the conventional hair tonic of comparative example 1, a 6 month use test was conducted for 10 male pattern baldness (42 to 53 years old). went. After use, a questionnaire survey was conducted on hair growth, thinning, and hair loss, and a comprehensive determination was made. As a result, the hair restoring agent containing the extract of rice bran cherry showed an excellent hair restoring effect (Table 2). During the test period, there was no skin problem and there was no problem with safety. There was also no problem with the deterioration of the prescription ingredients.

Figure 2011168522
Figure 2011168522

実験例3 ニキビ治療効果に関する使用試験
処方例5のニキビ治療用軟膏及び比較例2の従来の軟膏を用いて、各々ニキビに悩む男性15人(19〜28歳)を対照に1カ月の使用試験を行った。使用後、ニキビの改善(予防及び治療)効果についてアンケート調査を行い総合的に判定した。その結果、コメバツガザクラの抽出物を含有するニキビ治療用軟膏は優れたニキビの改善効果を示した(表3)。なお、試験期間中、皮膚トラブルは一人もなく、安全性においても問題なかった。また、処方成分の劣化についても問題なかった。

Experimental Example 3 Use Test for Acne Treatment Effect Using the acne treatment ointment of Formulation Example 5 and the conventional ointment of Comparative Example 2 for 15 months (19 to 28 years old) each suffering from acne, a 1 month use test Went. After use, a questionnaire survey was conducted on the effect of acne improvement (prevention and treatment) to make a comprehensive assessment. As a result, the acne treatment ointment containing the extract of rice bran cherry showed an excellent acne improving effect (Table 3). During the test period, there was no skin problem and there was no problem with safety. There was also no problem with the deterioration of the prescription ingredients.

Figure 2011168522
Figure 2011168522

以上のことから、コメバツガザクラの抽出物は、優れた5α‐レダクターゼ阻害作用を有していた。また、本抽出物を含有する育毛剤及びニキビ治療用軟膏は、それぞれ優れた育毛効果、ニキビ予防及び治療効果を示し、安全性、安定性にも優れていた。従って、本発明の5α‐レダクターゼ阻害剤は男性型脱毛症、ニキビ、前立腺疾患等の予防又は治療に有効である。

From the above, the extract of rice bran cherry had an excellent 5α-reductase inhibitory action. Moreover, the hair restorer and acne treatment ointment containing this extract exhibited excellent hair growth effects, acne prevention and treatment effects, respectively, and were excellent in safety and stability. Therefore, the 5α-reductase inhibitor of the present invention is effective in preventing or treating male pattern alopecia, acne, prostate disease and the like.

Claims (4)

コメバツガザクラの抽出物を含有することを特徴とするテストステロン‐5α‐レダクターゼ阻害剤。 A testosterone-5α-reductase inhibitor characterized by containing an extract of rice bran cherry. コメバツガザクラの抽出物を含有することを特徴とする育毛剤。 A hair restorer comprising an extract of rice bran cherry. コメバツガザクラの抽出物を含有することを特徴とするニキビ治療剤。 A therapeutic agent for acne characterized by containing an extract of rice bran cherry. コメバツガザクラの抽出物を含有することを特徴とする前立腺疾患の治療剤。

A therapeutic agent for prostate diseases, comprising an extract of rice bran cherry.

JP2010033083A 2010-02-18 2010-02-18 Testosterone-5α-reductase inhibitor Active JP5971833B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010033083A JP5971833B2 (en) 2010-02-18 2010-02-18 Testosterone-5α-reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010033083A JP5971833B2 (en) 2010-02-18 2010-02-18 Testosterone-5α-reductase inhibitor

Publications (2)

Publication Number Publication Date
JP2011168522A true JP2011168522A (en) 2011-09-01
JP5971833B2 JP5971833B2 (en) 2016-08-17

Family

ID=44683022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010033083A Active JP5971833B2 (en) 2010-02-18 2010-02-18 Testosterone-5α-reductase inhibitor

Country Status (1)

Country Link
JP (1) JP5971833B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011211958A (en) * 2010-03-31 2011-10-27 Nippon Menaade Keshohin Kk Undifferentiation-maintaining agent for stem cell and growth-promoting agent

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5753401A (en) * 1980-09-17 1982-03-30 Pola Chem Ind Inc Hair nourishing agent for promoting hair growth
JPH05310526A (en) * 1992-05-07 1993-11-22 Eisai Co Ltd Cell differentiation promotor
JPH0725731A (en) * 1993-07-08 1995-01-27 Kyodo Kumiai Ratesuto Hair tonic
JPH07258042A (en) * 1994-03-15 1995-10-09 Sanwa Shiyouyaku Kk Novel hair restoration and growth stimulant
JP2003321330A (en) * 2002-04-30 2003-11-11 Lion Corp Hair growth tonic composition
KR100863618B1 (en) * 2007-04-19 2008-10-15 바이오스펙트럼 주식회사 Compositions for improving skin conditions comprising protocatechuic acid

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5753401A (en) * 1980-09-17 1982-03-30 Pola Chem Ind Inc Hair nourishing agent for promoting hair growth
JPH05310526A (en) * 1992-05-07 1993-11-22 Eisai Co Ltd Cell differentiation promotor
JPH0725731A (en) * 1993-07-08 1995-01-27 Kyodo Kumiai Ratesuto Hair tonic
JPH07258042A (en) * 1994-03-15 1995-10-09 Sanwa Shiyouyaku Kk Novel hair restoration and growth stimulant
JP2003321330A (en) * 2002-04-30 2003-11-11 Lion Corp Hair growth tonic composition
KR100863618B1 (en) * 2007-04-19 2008-10-15 바이오스펙트럼 주식회사 Compositions for improving skin conditions comprising protocatechuic acid

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
FREE PHENOLIC ACIDS OF ERICACEOUS PLANTS OF SIBERIA AND THE RUSSIAN FAR EAST, RASTITEL'NYE RESURSY,, JPN6013034516, ISSN: 0002770325 *
フレグランスジャーナル、1997年5月15日、第25巻、第5号、67〜72頁, JPN6015007743, ISSN: 0003016817 *
フレグランスジャーナル、NO.74 VOL.13, NO.5、1985年9月25日、25〜29頁, JPN6015007735, ISSN: 0003016820 *
フレグランスジャーナル、VOL.13, NO.2、1985年3月25日、91〜94頁, JPN6015007734, ISSN: 0003016819 *
フレグランスジャーナル臨時増刊 NO.16、1999年2月20日、122〜128頁, JPN6015007745, ISSN: 0003016818 *
新化粧品ハンドブック、日光ケミカルズ株式会社 外4社、2006年10月30日、358,361〜387, JPN6015007738, ISSN: 0003016815 *
新化粧品ハンドブック、日光ケミカルズ株式会社 外4社、2006年10月30日、542〜544頁, JPN6015007740, ISSN: 0003016816 *
新化粧品ハンドブック、日光ケミカルズ株式会社 外4社、2006年10月30日、545,551頁, JPN6015007731, ISSN: 0003016814 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011211958A (en) * 2010-03-31 2011-10-27 Nippon Menaade Keshohin Kk Undifferentiation-maintaining agent for stem cell and growth-promoting agent

Also Published As

Publication number Publication date
JP5971833B2 (en) 2016-08-17

Similar Documents

Publication Publication Date Title
JP5085018B2 (en) Hair restorer
KR20070056207A (en) Testosterone 5alpha-reductase inhibitor containing vitis radix extract
KR101287052B1 (en) Testosterone 5alpha-reductase inhibitor containing elsholtziae herba extract
JP5654214B2 (en) Hair suppressant and skin cosmetic for hair suppression
JP4628840B2 (en) Testosterone-5α-reductase inhibitor
JP2003095858A (en) Skin care preparation
JPH08268844A (en) Hair nourishing agent
JP2015124188A (en) Sebum synthesis inhibitor
JP5971833B2 (en) Testosterone-5α-reductase inhibitor
JP6267957B2 (en) Sebum synthesis inhibitor
JP4975225B2 (en) Hair restorer
JP2008280249A (en) Skin-lightening cosmetic
JP5632619B2 (en) Testosterone-5α-reductase inhibitor
JP5666344B2 (en) Hair restorer
JP2005145902A (en) TESTOSTERONE-5alpha-REDUCTASE INHIBITOR
JP2011219462A (en) Cosmetic or phamaceutical composition containing kuzu flower extract
JP4694068B2 (en) Testosterone-5α-reductase inhibitor
JP6433678B2 (en) External preparations and internal preparations containing the extract
JPH08301730A (en) Hair growing agent
JP2006169133A (en) HAIR TONIC, ANTI-ANDROGENIC AGENT, TESTOSTERONE 5alpha-REDUCTASE INHIBITOR AND HAIR COSMETIC
JP2005126366A (en) TESTOSTERONE-5alpha-REDUCTASE INHIBITOR
JP2007191438A (en) Desmosome degradation-promoting agent
JP4803698B2 (en) Anti-aging agent, estrogenic agent, anti-androgen agent, hair restorer, testosterone 5α-reductase inhibitor, skin cosmetic and hair cosmetic
JP2006176424A (en) TESTOSTERONE 5alpha-REDUCTASE INHIBITOR AND HAIR-GROWING COSMETIC
JPH1135426A (en) Composition for head

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121219

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140516

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150126

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150203

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160513

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160711

R150 Certificate of patent or registration of utility model

Ref document number: 5971833

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250